VERA vs XNCR: stock comparison and AI forecast
Vera Therapeutics, Inc. (VERA) and Xencor Inc (XNCR) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
VERA Vera Therapeutics, Inc.
- Price
- $30.71 -11.0% · 6M
- Market Cap
- $2.21B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
XNCR Xencor Inc
- Price
- $30.64 +138.4% · 6M
- Market Cap
- $2.60B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- XNCR is 1.2 times larger than VERA by market capitalization ($2.60B against $2.21B).
- Over the last six months XNCR returned +138.4% and VERA -11.0%.
- XNCR carries 0.37 times debt per unit of equity, against 0.31 times for VERA.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | VERA | XNCR |
|---|---|---|
| Market Cap | $2.21B | $2.60B |
| P/B Ratio | 5.43x | 4.65x |
| EPS | $-6.67 | $-2.24 |
| Book Value/Share | $5.66 | $7.54 |
| Revenue/Share | – | $1.95 |
| FCF/Share | $-4.70 | $-2.37 |
Profitability & Margins
| Metric | VERA | XNCR |
|---|---|---|
| ROE | -98.6% | -21.0% |
| ROA | -75.4% | -15.3% |
| ROIC | -85.8% | -21.0% |
| Operating Margin | – | -100.7% |
| Net Margin | – | -81.4% |
| EBT Margin | – | -79.8% |
| Tax Rate | – | -2.0% |
Financial Health
| Metric | VERA | XNCR |
|---|---|---|
| Current Ratio | 10.92x | 6.54x |
| D/E Ratio | 0.31x | 0.37x |
| Financial Leverage | 1.31x | 1.37x |
| Interest Coverage | -68.3x | -9267.0x |
| Working Capital | $479M | $422M |
Cash Flow
| Metric | VERA | XNCR |
|---|---|---|
| Operating Cash Flow | -$339M | -$172M |
| Free Cash Flow | -$339M | -$176M |
| Capital Spending | -$260K | -$4M |
| FCF/Sales | – | -121.9% |
| CapEx/Sales | – | 2.8% |
Operational Efficiency
| Metric | VERA | XNCR |
|---|---|---|
| Asset Turnover | – | 0.19x |
| Receivables Turnover | – | 2.2x |
| Fixed Assets Turnover | – | 2.9x |
| Days Sales Outstanding | – | 163 days |
Income Statement
| Metric | VERA | XNCR |
|---|---|---|
| Total Revenue | – | $145M |
| Operating Income | -$416M | -$146M |
| Net Income | -$402M | -$118M |
| R&D Expense | $262M | $286M |
Dividend & Shareholder Information
| Metric | VERA | XNCR |
|---|---|---|
| Shares Outstanding | 72M | 74M |
VERA vs XNCR: stock comparison and AI forecast
Which is bigger, VERA or XNCR?
XNCR is 1.2 times larger than VERA by market capitalization ($2.60B against $2.21B).
Which stock performed better over the last six months, VERA or XNCR?
Over the last six months XNCR returned +138.4% and VERA -11.0%.
Which one does Intratio's AI model rank higher, VERA or XNCR?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.